Zhong Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhong Luo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Haiqing Zhang
Department of Neurology, Affiliated Hospital of Zunyi Medical University, Zunyi, China
1 shared publication - Juan Yang
Department of Neurology Key Laboratory of Brain Function and Brain Disease Prevention and Treatment of Guizhou Province (ZSYS(2025)030), Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China
1 shared publication Linhai Zhang
Department of Neurology, Affiliated Hospital of Zunyi Medical University, Dalian road. Zunyi, China
1 shared publicationTao Liang
Department of Neurology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China
1 shared publication- Tao Liang
Department of Neurology Affiliated Hospital of Zunyi Medical University Zunyi China
1 shared publication Xiaolin Hu
Department of Surgery Spine, the Affiliated Hospital of Zunyi Medical University, Zunyi, China
1 shared publication
Latest Publications
- Open Access
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31378
Hereditary motor and sensory neuropathy with SOD1-mutant: A case report
Rationale: Hereditary motor-sensory peripheral neuropathy, or Charot-Marie-Tooth (CMT) Charcot-Marie-Tooth disease is an inherited peripheral neuropathy characterized by progressive limb weakness and muscle atrophy. As the disease progresses, sensory and autonomic involvement may occur. We report a case of CMT associated with SOD1 gene mutation, in order to provide new ideas for clinical disease diagnosis. Patient concerns: A 50-years-old female patient was admitted to the hospital with “progressive weakness of the right lower extremity for 5 years, aggravating, and weakness of the left lower extremity for 4 months”. Diagnosis: The patient was diagnosed CMT. Intervention: Nerve nutrition and rehabilitation therapy were given, but the patient’s condition still did not improve significantly. Outcomes: The improvement of symptoms was not obvious. Lessons: The clinical manifestations and electromyography results of this patient are consistent with the characteristics of CMT. The peripheral nerve-related hereditary gene test found mutation in SOD1. It is possible that this mutation is linked to CMT. The disease is a neurodegenerative disease, that may be slowed by physical therapy and rehabilitation, but could not be healed.
- 28 October 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (43) , e31378
Open AccessHereditary motor and sensory neuropathy with SOD1-mutant: A case report
Rationale: Hereditary motor-sensory peripheral neuropathy, or Charot-Marie-Tooth (CMT) Charcot-Marie-Tooth disease is an inherited peripheral neuropathy characterized by progressive limb weakness and muscle atrophy. As the disease progresses, sensory and autonomic involvement may occur. We report a case of CMT associated with SOD1 gene mutation, in order to provide new ideas for clinical disease diagnosis. Patient concerns: A 50-years-old female patient was admitted to the hospital with “progressive weakness of the right lower extremity for 5 years, aggravating, and weakness of the left lower extremity for 4 months”. Diagnosis: The patient was diagnosed CMT. Intervention: Nerve nutrition and rehabilitation therapy were given, but the patient’s condition still did not improve significantly. Outcomes: The improvement of symptoms was not obvious. Lessons: The clinical manifestations and electromyography results of this patient are consistent with the characteristics of CMT. The peripheral nerve-related hereditary gene test found mutation in SOD1. It is possible that this mutation is linked to CMT. The disease is a neurodegenerative disease, that may be slowed by physical therapy and rehabilitation, but could not be healed.
- Open Access
- 28 May 2021
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-5
Graves’ disease with anti-GQ1b antibody syndrome: a rare case report
Background: Graves’ disease and anti-GQ1b antibody syndrome are both autoimmune diseases, and there have been few reports on whether there is a correlation between the two. In this study, we present the case of a woman who was diagnosed with Graves’ disease and anti-GQ1b antibody syndrome in succession. Case presentation: The chief complaints of this patient were limb weakness and blurred vision. Graves’ disease was diagnosed by examination of thyroid function and thyroid autoantibodies, but the clinical symptoms were not relieved after antihyperthyroidism treatment. Finally, it was found that Graves’ disease was complicated by anti-GQ1b antibody syndrome, and the symptoms were relieved after treatment with glucocorticoids and intravenous immunoglobulin. We also explored the possible mechanism of these diseases through a literature review. Conclusions: We report a rare case of the cooccurrence of Graves’ disease and anti-GQ1b antibody syndrome. Immune dysregulation might be the pathogenesis of the association, but there is no precise supporting evidence, and more research is needed.
- 28 May 2021
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1) , 1-5
Open AccessGraves’ disease with anti-GQ1b antibody syndrome: a rare case report
Background: Graves’ disease and anti-GQ1b antibody syndrome are both autoimmune diseases, and there have been few reports on whether there is a correlation between the two. In this study, we present the case of a woman who was diagnosed with Graves’ disease and anti-GQ1b antibody syndrome in succession. Case presentation: The chief complaints of this patient were limb weakness and blurred vision. Graves’ disease was diagnosed by examination of thyroid function and thyroid autoantibodies, but the clinical symptoms were not relieved after antihyperthyroidism treatment. Finally, it was found that Graves’ disease was complicated by anti-GQ1b antibody syndrome, and the symptoms were relieved after treatment with glucocorticoids and intravenous immunoglobulin. We also explored the possible mechanism of these diseases through a literature review. Conclusions: We report a rare case of the cooccurrence of Graves’ disease and anti-GQ1b antibody syndrome. Immune dysregulation might be the pathogenesis of the association, but there is no precise supporting evidence, and more research is needed.